Welcome to our dedicated page for C3.Ai SEC filings (Ticker: AI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
C3.ai, Inc. filings document the regulatory record of an enterprise AI application software company listed on the NYSE. Recent 8-K disclosures cover operating and financial results, material events, governance matters, stockholder voting outcomes, and exhibits tied to corporate actions.
The company’s filings also describe board composition, director compensation, the 2025 Inducement Plan for equity-based employment awards, Class A common stock reserved for plan issuance, and annual meeting matters such as director elections, executive compensation votes, and auditor ratification. Other filings address securities litigation disclosures involving statements in the company’s IPO registration statement and related Exchange Act and Securities Act claims.
C3.ai, Inc. reported significantly weaker results for the quarter and nine months ended January 31, 2026. Quarterly revenue fell to $53.3 million from $98.8 million a year earlier, with subscription revenue at $48.2 million and professional services at $5.1 million. The company posted a quarterly net loss of $133.4 million, compared with a loss of $80.2 million, as operating expenses and stock-based compensation remained high.
For the nine-month period, revenue was $198.7 million versus $280.3 million, while net loss widened to $354.8 million. Operating cash outflow was $135.8 million. As of January 31, 2026, C3.ai held $88.8 million in cash and cash equivalents and $533.1 million in marketable securities, with stockholders’ equity of $719.5 million.
Remaining performance obligations were $225.4 million, with about $136.0 million expected to be recognized over the next 12 months. The company approved a restructuring plan that includes a 26% global workforce reduction and an expected $10.0–$12.0 million in restructuring charges in the fourth quarter of fiscal 2026 to reduce cash burn and non‑employee costs.
C3.ai, Inc. director Jim H. Snabe reported an open-market purchase of 25,000 shares of Class A Common Stock at $9.00 per share on March 9, 2026. After this transaction, he directly holds 395,000 shares.
The filing also shows an additional 28,000 shares held indirectly through BJHS Invest ApS, an entity of which he is the sole member. This mix of direct and indirect holdings outlines his overall equity exposure to C3.ai following the reported trade.
C3.ai, Inc. reported that Chief Financial Officer Hitesh Lath received a grant of options for 100,000 shares of common stock. The options were awarded at an exercise price of $0.00 per share. According to the vesting terms, 33.33% of the grant vests on the one-year anniversary of the vesting commencement date, with 8.33% vesting quarterly over the following two years, contingent on continued service.
C3.ai, Inc. Executive Chairman Thomas M. Siebel reported several equity transactions involving the company’s Class A common stock and related equity awards. On March 1, 2026, he exercised 32,736 Restricted Stock Units, converting them into the same number of Class A shares at a stated price of $0.00 per share.
On March 2, 2026, Siebel sold 17,655 Class A shares in an open‑market transaction at a weighted‑average price of $7.79 per share, with individual trades ranging from $7.75 to $7.82. On March 3, 2026, he made bona fide gifts totaling 15,081 Class A shares from his direct holdings and an additional 15,081 shares from entities such as The Siebel Living Trust and affiliated investment vehicles, which hold shares associated with him.
C3.ai, Inc. reported fiscal Q3 2026 results and announced a major restructuring plan. Total revenue was $53.3 million, with subscription revenue of $48.2 million, or 90% of total. GAAP gross margin was 17%, and GAAP net loss per share was $(0.94), while non-GAAP net loss per share was $(0.40).
The company is cutting approximately 26% of its global workforce and targeting about 30% lower annualized non-employee costs, expecting roughly $10.0 million to $12.0 million of pre-tax restructuring charges in Q4 2026. Management expects these actions to deliver about $135 million of annual non-GAAP operating expense savings and support a path toward profitability.
Q3 cash, cash equivalents, and marketable securities totaled $621.9 million. Federal, defense, and aerospace bookings rose 134% year over year and made up 55% of total bookings, and C3 AI closed 44 agreements in the quarter, including new and expanded work with several major government and commercial customers. For Q4 2026, the company guides revenue to $48.0 million to $52.0 million and a non-GAAP operating loss of $(56.0) million to $(64.0) million.
C3.ai director John E. Hyten reported a disposition of Class A common stock tied to equity compensation. On February 15, 2026, he disposed of 2,500 shares to the issuer at $10.78 per share, reflecting that 2,500 of 5,000 vested restricted stock units were settled in cash. After this transaction, he beneficially owned 125,658 Class A shares directly and 102,886 shares indirectly through Hyten Group LLC, where he is the manager and sole member.
C3.ai, Inc. received an amended Schedule 13G from several Susquehanna-affiliated entities reporting a passive ownership stake in its Class A common stock. The Reporting Persons collectively report beneficial ownership of 3,982,270 Shares, representing 2.9% of the class.
The filing notes that Susquehanna Investment Group’s position includes options to buy 21,400 Shares, and Susquehanna Securities, LLC’s position includes options to buy 2,573,300 Shares. Based on the company’s Form 10-Q, there were 137,253,289 Shares outstanding as of November 24, 2025.
The Reporting Persons state that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of C3.ai. Each entity disclaims beneficial ownership of Shares held directly by the other Reporting Persons.
C3.ai Executive Chairman Thomas M. Siebel, a director and 10% owner, reported a planned stock transaction in Class A common shares. On February 10, 2026, he exercised stock options for 511,732 shares at an exercise price of $2.04 per share and then sold 511,732 shares in open-market transactions at a weighted-average price of $11.66 per share.
The filing shows he directly held 722,362 Class A shares afterward, plus additional indirect holdings through various entities, including The Siebel Living Trust, First Virtual Holdings LLC, Siebel Asset Management partnerships, and The Siebel 2011 Irrevocable Children's Trust. The activity was carried out under a pre-established Rule 10b5-1 trading plan dated September 20, 2024, and the exercised option was fully vested.
C3.ai Executive Chairman Thomas M. Siebel, a director and 10% owner, reported RSU vesting, related share issuance, a tax-withholding sale, and internal transfers of Class A Common Stock. On February 1, 2026, 53,125 Restricted Stock Units vested and were settled into 53,125 shares of Class A stock at an exercise price of $0, increasing his direct holdings to 775,487 shares.
On February 2, 2026, 27,605 Class A shares were sold at a weighted-average price of $10.81, with the issuer automatically withholding and selling these shares to satisfy tax obligations tied to the RSU vesting. On February 3, 2026, 25,520 shares were transferred from direct ownership to The Siebel Living Trust u/a/d 7/27/93 and 25,520 shares were received by that trust, both at $0. Indirect holdings are also reported in several related entities, including The Siebel Living Trust, First Virtual Holdings, LLC, and Siebel Asset Management partnerships.
Form 144 discloses planned sales of 73,500 shares of Class A common stock through J.P. Morgan Securities on the NYSE, with an aggregate market value of 809,970.
The shares were acquired via an RSU vest on 02/02/2026. The filing also lists multiple Class A common stock sales during the prior three months by Thomas M. Siebel and the Siebel Living Trust.